Allurion Technologies shares soared 200% Friday as it planned to test its gastric balloon with the key ingredient in popular weight-loss drugs to see if the combination improves patients' muscle mass.
6d
-- Allurion Technologies a déclaré vendredi avoir signé un accord définitif avec certains investisseurs institutionnels pour ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback